StemCells Inc. is a top biotech company developing stem cell-based therapies. They have a deep pipeline that includes already ongoing trials for a variety of diseases. I invited company leadership to do an interview and they graciously accepted. Below is the interview with CFO Greg Schiffman (picture at left from LinkedIn) including what I thought […]
Interview with StemCells Inc. leadership on hot topics Read More »
Who is trying, via the name BioGatekeeper, Inc., to nullify Yamanaka’s patent on cellular reprogramming to produce induced pluripotent stem (iPS) cells? The readers of this blog never cease to amaze me. What an informed, energetic, bright group. Within just days they may have collectively shed some light on an intriguing mystery in the stem cell field surrounding the
Blog readers investigate BioGatekeeper, the Yamanaka patent challenger Read More »
Clare Wilson over at the NewScientist has reported the case of a woman given an experimental stem cell treatment in Portugal for a spinal cord injury who later developed a strange tumor consisting of nose tissue. I highly recommend going over to that site and reading her excellent article. What’s the deal with this case? The woman was
Woman grows nose tumor in spine after stem cell injection Read More »
The Cell Surgical Network is a for-profit network of clinics offering various stem cell-related interventions, which began with the California Stem Cell Treatment Center. I have interviewed Drs. Elliot Lander and Mark Berman of the Network in past (Part 1, Part 2) and I raised some concerns about the network in a follow up Part 3 post,
Update on Cell Surgical Network IRB Status Read More »
Each year I make predictions for the stem cell field for the coming year. In today’s post I write about my top 10 stem cell predictions for 2014. You can see my predictions for 2013 here (see predictions for 2011 and 2012 predictions, which are kind of fun to read to see what was on the “mind” of the field
Stem Cell Predictions for 2014 Read More »
Every year I do predictions for the stem cell field for the coming year. You can see my full post on my predictions for this year here. Stay tuned soon for my predictions for 2014. How’d I do for 2013 with my predications? Each prediction for this year that I made last year is bolded
How’d stem cell predictions for 2013 fare? Read More »
Osiris, a cellular therapy biotech, recently received a so-called “untitled letter” from the FDA. The text of the letter seems on the whole negative in my opinion, while the company’s public reaction to the letter on the other hand could be seen paradoxically as rather cheery. What’s going on here? With Halloween coming, one has
Osiris FDA Letter: Trick or Treat? Read More »
What’s the deal with IntelliCell Biosciences, headed up by Dr. Steven Victor? Sometimes science can move at warp speed and that is even more true of the stem cell field. One stem cell establishment that seems to be in a particularly intense period of activity and that has drawn a great deal of attention lately
Interview with Dr. Steven Victor of IntelliCell Biosciences (SVFC) Read More »
In the past week I’ve been getting an unprecedented number of emails, blog comments, and even phone calls about IntelliCell Biosciences of NY (stock symbol SVFC). It’s quite remarkable and I’ve had to moderate many comments related to IntelliCell for content not following this blog’s comment rules. The grapevine is smoking hot on this company. It’s
Stem Cell Grapevine on Fire: Big Day & Week Ahead for IntelliCell (SVFC) Read More »
Over at Health in the Global Village, Leigh Turner yesterday published an excellent piece updating us all on the latest news on Korean stem cell company RNL BIo (알앤엘바이오) and its leader, Dr. Jeong Chan Ra (라정찬 ). Addition: The story was reported in several Korean news outlets including Hani here. A video here by MBC News of Korea, one
Jeong Chan Ra Arrest: Can RNL Bio (알앤엘바이오) Survive? Read More »